|
| | HB3355 Enrolled | | LRB102 16962 RLC 22380 b |
|
|
1 | | AN ACT concerning criminal law.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Illinois Controlled Substances Act is |
5 | | amended by changing Section 313 and by adding Section 315.6 as |
6 | | follows:
|
7 | | (720 ILCS 570/313) (from Ch. 56 1/2, par. 1313)
|
8 | | Sec. 313. (a) Controlled substances which are lawfully |
9 | | administered in
hospitals or institutions licensed under the |
10 | | Hospital Licensing Act shall
be exempt from the requirements |
11 | | of Sections 312 , 315.6, and 316, except
that the
prescription |
12 | | for the controlled substance shall be in writing on the
|
13 | | patient's record, signed by the prescriber, and dated, and |
14 | | shall state the
name and quantity of controlled substances |
15 | | ordered and the quantity
actually administered. The records of |
16 | | such prescriptions shall be
maintained for two years and shall |
17 | | be available for inspection by officers
and employees of the |
18 | | Illinois State Police and the Department of Financial and
|
19 | | Professional Regulation. |
20 | | The exemption under this subsection (a) does not apply to |
21 | | a prescription (including an outpatient prescription from an |
22 | | emergency department or outpatient clinic) for more than a |
23 | | 72-hour supply of a discharge medication to be consumed |
|
| | HB3355 Enrolled | - 2 - | LRB102 16962 RLC 22380 b |
|
|
1 | | outside of the hospital or institution.
|
2 | | (b) Controlled substances that can lawfully be |
3 | | administered or dispensed
directly to a patient in a long-term |
4 | | care facility licensed by the Department
of Public Health as a |
5 | | skilled nursing facility, intermediate care facility, or
|
6 | | long-term care facility for residents under 22 years of age, |
7 | | are exempt from
the requirements of Section 312 except that a |
8 | | prescription
for a
Schedule II controlled substance must be |
9 | | either a prescription signed
by the prescriber or a |
10 | | prescription transmitted by the prescriber or
prescriber's |
11 | | agent to the dispensing pharmacy by facsimile. The
facsimile |
12 | | serves as the original prescription and must be maintained for |
13 | | 2
years from the date of issue in the same manner as a written |
14 | | prescription
signed by the prescriber.
|
15 | | (c) A prescription that is generated for a Schedule II |
16 | | controlled substance
to be compounded for direct |
17 | | administration to a patient in a private
residence, long-term |
18 | | care facility, or hospice program
may be transmitted by
|
19 | | facsimile by the prescriber or the prescriber's agent to the |
20 | | pharmacy providing
the home infusion services. The facsimile |
21 | | serves as the original
prescription for purposes of this |
22 | | paragraph (c) and it shall be maintained in
the same manner as |
23 | | the original prescription.
|
24 | | (c-1) A prescription generated for a Schedule II |
25 | | controlled substance for a
patient residing in a hospice |
26 | | certified by Medicare under Title XVIII of the
Social Security |
|
| | HB3355 Enrolled | - 3 - | LRB102 16962 RLC 22380 b |
|
|
1 | | Act or
licensed by the State may be transmitted by the |
2 | | practitioner or the
practitioner's
agent to the dispensing |
3 | | pharmacy by facsimile or electronically as provided in Section |
4 | | 311.5. The practitioner or
practitioner's
agent must note on |
5 | | the prescription that the patient is a hospice patient. The
|
6 | | facsimile or electronic record serves as the original |
7 | | prescription for purposes of this
paragraph (c-1) and it shall |
8 | | be maintained in the same manner as the original
prescription.
|
9 | | (d) Controlled substances which are lawfully administered
|
10 | | and/or dispensed
in drug abuse treatment programs licensed by |
11 | | the Department shall be exempt
from the requirements of |
12 | | Sections 312 and 316, except that the
prescription
for such |
13 | | controlled substances shall be issued and authenticated
on |
14 | | official prescription logs prepared and maintained in |
15 | | accordance with 77 Ill. Adm. Code 2060: Alcoholism and |
16 | | Substance Abuse Treatment and Intervention Licenses, and in |
17 | | compliance with other applicable State and federal laws. The |
18 | | Department-licensed drug treatment program shall report |
19 | | applicable prescriptions via electronic record keeping |
20 | | software approved by the Department. This software must be |
21 | | compatible with the specifications of the Department. Drug |
22 | | abuse treatment programs shall report to the Department |
23 | | methadone prescriptions or medications dispensed through the |
24 | | use of Department-approved File Transfer Protocols (FTPs). |
25 | | Methadone prescription records must be maintained in |
26 | | accordance with the applicable requirements as set forth by |
|
| | HB3355 Enrolled | - 4 - | LRB102 16962 RLC 22380 b |
|
|
1 | | the Department in accordance with 77 Ill. Adm. Code 2060: |
2 | | Alcoholism and Substance Abuse Treatment and Intervention |
3 | | Licenses, and in compliance with other applicable State and |
4 | | federal laws. |
5 | | (e) Nothing in this Act shall be construed to limit the |
6 | | authority of a hospital pursuant to Section 65-45 of the Nurse |
7 | | Practice Act to grant hospital clinical privileges to an |
8 | | individual advanced practice registered nurse to select, order |
9 | | or administer medications, including controlled substances to |
10 | | provide services within a hospital. Nothing in this Act shall |
11 | | be construed to limit the authority of an ambulatory surgical |
12 | | treatment center pursuant to Section 65-45 of the Nurse |
13 | | Practice Act to grant ambulatory surgical treatment center |
14 | | clinical privileges to an individual advanced practice |
15 | | registered nurse to select, order or administer medications, |
16 | | including controlled substances to provide services within an |
17 | | ambulatory surgical treatment center.
|
18 | | (Source: P.A. 100-513, eff. 1-1-18 .)
|
19 | | (720 ILCS 570/315.6 new) |
20 | | Sec. 315.6. Risks of dependence on opioids. |
21 | | (a) Definitions. As used in this Section: |
22 | | (1) "Opioid" means a narcotic drug or substance that |
23 | | is a Schedule II controlled substance under paragraph (1), |
24 | | (2), (3), or (5) of subsection (b) or under subsection (c) |
25 | | of Section 206 of this Act. |
|
| | HB3355 Enrolled | - 5 - | LRB102 16962 RLC 22380 b |
|
|
1 | | (2) "Department" means the Department of Human |
2 | | Services. |
3 | | (b) The Department shall develop and make available on its |
4 | | website information on the risks of developing a physical or |
5 | | psychological dependence on opioids and any alternative |
6 | | treatments, including the Opioid Alternative Pilot Program. |
7 | | (c) The Department shall develop and make available upon |
8 | | request to all prescribers, pharmacists, and patients in the |
9 | | State a pamphlet which explains the risks of developing a |
10 | | physical or psychological dependence on opioids. This pamphlet |
11 | | may contain any information which the Secretary of the |
12 | | Department deems necessary and may be revised by the |
13 | | Department whenever new information becomes available. The |
14 | | pamphlet shall be downloadable from the Department's website. |
15 | | (d) A pharmacist shall, prior to dispensing an opioid that |
16 | | is a Schedule II controlled substance, furnish the pamphlet or |
17 | | information therein developed by the Department and discuss |
18 | | the risks of developing a physical or psychological dependence |
19 | | on opioids.
|
20 | | Section 99. Effective date. This Act takes effect upon |
21 | | becoming law. |